These findings emphasise the significant role of GSTM3 in IR-induced ferroptosis and radiotherapy sensitivity, providing valuable insights for the development of promising treatment strategies targeting radiation-resistant or recurrent NPC. The gene discussed is GSTM3; the disease is nasopharyngeal carcinoma.